Evidence map›Paper›PMID 23462798›Full record

ArticleDiabetologia2013

Hypothalamic ATF3 is involved in regulating glucose and energy metabolism in mice.

Y-S Lee, T Sasaki, M Kobayashi, O Kikuchi, H-J Kim, H Yokota-Hashimoto, M Shimpuku, V-Y Susanti, Y Ido-Kitamura, K Kimura and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Eugenol inhibits preadipocyte differentiation and lipid accumulation via upregulating ATF3.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2025
    Article
  4. Article
  5. Cells · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Activating Transcription Factor 3 (Frontiers in molecular neuroscience · 2018
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Y-S LeeMetabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8512, Japan.
T Sasaki
M Kobayashi
O Kikuchi
H-J Kim
H Yokota-Hashimoto
M Shimpuku
V-Y Susanti
Y Ido-Kitamura
K Kimura
H Inoue
M Tanaka-Okamoto
H Ishizaki
J Miyoshi
S Ohya
Y Tanaka
S Kitajima
T Kitamura
Gunma University · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JPTokyo Medical and Dental University · JPKanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisThe pancreas and hypothalamus are critical for maintaining nutrient and energy homeostasis, and combined disorders in these organs account for the onset of the metabolic syndrome. Activating transcription factor 3 (ATF3) is an adaptive response transcription factor. The physiological role of ATF3 in the pancreas has been controversial, and its role in the hypothalamus remains unknown. To elucidate the roles of ATF3 in these organs, we generated pancreas- and hypothalamus-specific Atf3 knockout (PHT-Atf3-KO) mice in this study.

methodsWe crossed mice bearing floxed Atf3 alleles with Pdx1-cre mice, in which cre is specifically expressed in the pancreas and hypothalamus, and analysed metabolic variables, pancreatic morphology, food intake, energy expenditure and sympathetic activity in adipose tissue. We also used a hypothalamic cell line to investigate the molecular mechanism by which ATF3 regulates transcription of the gene encoding agouti-related protein (Agrp).

resultsAlthough PHT-Atf3-KO mice displayed better glucose tolerance, neither plasma glucagon nor insulin level was altered in these mice. However, these mice exhibited higher insulin sensitivity, which was accompanied by a leaner phenotype due to decreased food intake and increased energy expenditure. We also observed decreased hypothalamic Agrp expression in PHT-Atf3-KO mice. Importantly, an increase in ATF3 levels is induced by fasting or low glucose in the hypothalamus. We also showed that ATF3 interacts with forkhead box-containing protein, O subfamily 1 (FoxO1) on the Agrp promoter and activates Agrp transcription. CONCLUSIONS/

interpretationOur results suggest that ATF3 plays an important role in the control of glucose and energy metabolism by regulating Agrp.

Indexed as

Energy MetabolismActivating Transcription Factor 3Agouti-Related ProteinAllelesAnimalsCell LineForkhead Box Protein O1Forkhead Transcription FactorsGlucoseHypothalamusInsulinIntegrasesIslets of LangerhansMetabolic SyndromeMiceMice, KnockoutActivating Transcription Factor 3Agouti-Related ProteinAgrp protein, mouseAtf3 protein, mouseCre recombinaseForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseGlucoseInsulinIntegrases

Identifiers

PMID23462798
PMCPMC3648686
OpenAlexW2088905995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.